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Intr
Out-of-Hospital Cardiac Arrest (OOHCA) is associated
with a poor prognosis. Targeted temperature management
(TTM) within Intensive Care (ICU) including therapeutic
hypothermia (TH) aims to reduce cerebral reperfusion
injury and improve neurological outcomes.
Within Northern Ireland (NI), Craigavon Area Hospital
(CAH) is the only ICU to implement TH using an intra-
vascular cooling device (Coolgard 3000©, Alsius UK®)
The benefit of TH has recently been disputed and many
ICUs within NI have since adopted TTM to 36°C in survi-
vors of OOHCA [1].
In view of this we aimed to benchmark our use of TH
to 32-34°C, using intravascular cooling against best
practice at the time of data collection.
Objectives
To assess:
· Demographics of patients receiving TH within
CAH ICU
· Implementation, maintenance and temperature
control during TH using intravascular cooling
· Outcomes of patients receiving TH
Against standards used in published reference jour-
nals [2,3]
Methods
Retrospective, observational chart-based data collection.
40 patients admitted to CAH ICU, who received TH
via intravascular cooling catheter (24/5/2010-30/11/2012),
were identified from the Intensive Care National Audit
and Research Centre (ICNARC) database.




Overall our outcomes for a mixed ICU population with
broad inclusion criteria for TH are comparable with
those of published studies [2].
The use of intravascular cooling for TH was asso-
ciated with minimal use of muscle relaxants allowing
early neurological prognostication in our patient group.
Craigavon Area Hospital, Department of Anaesthesia and Intensive Care,
Craigavon, Northern Ireland, United Kingdom
Table 1 Indications for TH.
OOHCA with shockable rhythm 46%
OOHCA with non-shockable rhythm 23%
In-hospital cardiac arrest with shockable rhythm 11%
In-hospital cardiac arrest with non-shockable rhythm 8%
Respiratory Arrest 8%
Attempted suicide by hanging 4%
Table 2 TH using intravascular cooling.
Mean time from ROSC to target temperature of 32-34°C 8.3 hours
Mean duration of TH at temperature <34 °C 23.8
hours
Neuromuscular blockade use 28.5%
Rebound hyperthermia (>38°C) on cessation of active
cooling
45.1%
Mean duration of rebound hyperthermia 8.6 hours
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However intravascular cooling to 32-34°C was asso-
ciated with prolonged periods of rebound hyperthermia
in a significant minority of patients (45.1%, mean time
8.6 hours).
We believe that TH to 32-34°C, using intravascular
cooling, increases the risk of developing a rebound
hyperthermia that could potentially exacerbate acquired
neurological injury.
Our data supports the use of TTM to 36°C to mitigate
any potential effect of rebound hyperthermia is this patient
group.
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Table 3 Outcomes.
Mean length of ICU stay 5 days
ICU Mortality 45.7%
Destination at Hospital Discharge: Home 94.1%
Destination at Hospital Discharge: Hospice 5.9%
30 day mortality 60%
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